| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6130295 | Clinical Microbiology and Infection | 2014 | 8 Pages |
Abstract
The emergence of carbapenemases in Enterobacteriaceae has raised global concern among the scientific, medical and public health communities. Both the CDC and the WHO consider carbapenem-resistant Enterobacteriaceae (CRE) to constitute a significant threat that necessitates immediate action. In this article, we review the challenges faced by laboratory workers, infection prevention specialists and clinicians who are confronted with this emerging infection control issue.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
P. Savard, T.M. Perl,